Gilead posts solid Q1 2026 growth & raises full-year outlook on HIV momentum

Industry-academia partnership expands access to advanced life sciences analytics for Indian researchers

High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration

Mankind’s Rajeev Juneja contributes Rs. 9.17 crore to National Defence Fund

This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces

Vyome secures exclusive license from Impetis for selective JAK inhibitor programs

The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments

COMAU and Omron Robotics forge global automation alliance to accelerate smart manufacturing

Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors

Plus Therapeutics subsidiary clears key Medicare milestone

Paves way for CNS cancer test rollout

CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge

The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market

Dr. Reddy’s to participate in HSBC, Bank of America investor conferences

Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026

JB Chemicals reports muted Q4 FY26 as integration resets business

The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year

Shareholders approve J.B. Pharma merger with Torrent Pharma

Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held

Bajaj Healthcare FY26 revenue rises 12.6% to Rs 6,110 million

Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint

Lonza surges on biologics boom

Expands manufacturing push & locks in major growth deals

Lupin Q4 FY26 PBT jumps 115% to Rs 19,280 million

U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit

Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push

The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities

ICMR launches fellowship programme for biomedical scientists from developing countries

Initiative aims to strengthen South-South collaboration and capacity building in biomedical research

Dabur profit jumps 16% as FMCG growth gains pace

Hair care & quick commerce shine

Sanofi India partners with NHM MP to expand NCD, rare disease services

The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units

Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform

LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity

CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection

Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China

Safic-Alcan expands in India with majority stake in SA Ingredients

The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint